Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01988701

Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease

Lymphocyte Profiles and Activation Status in the Development of Chronic Graft-versus-Host Disease

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This research trial studies lymphocyte profiles and activation status in patients with graft-versus-host disease. Studying samples of blood in the laboratory from patients with cancer may help doctors identify and learn more about biomarkers related to graft-versus-host disease.

Detailed description

PRIMARY OBJECTIVES: I. To explore and assess changes in subsets and activation status of B-, T,-, and natural killer (NK) lymphocytes in peripheral blood following allogeneic stem cell transplant and how they may be associated with clinical events with an ultimate future goal of conducting a larger successor study to identify potential therapeutic targets based on its findings. SECONDARY OBJECTIVES: I. To assess the feasibility of obtaining and comparing patients with chronic graft-versus-host disease (cGVHD) with time-matched stem cell transplant (SCT) patients without cGVHD and identify logistical challenges with obtaining and processing samples in each of the subgroups of interest for these analyses. II. To assess and explore differences in lymphocyte subsets (B-, T-, and NK) between those with vs. without cGVHD. III. To assess and explore differences in cytokines in patients with cGVHD vs. those without. IV. To describe lymphocyte subsets and activation and explore how these may be related to specific clinical manifestations of cGVHD. OUTLINE: Blood samples are analyzed for activation status of B lymphocytes, T lymphocytes, and NK lymphocytes via flow cytometry, enzyme-linked immunosorbent assay (ELISA), enzyme-linked immunosorbent spot (ELISPOT), immunoblot, and microarray assays.

Conditions

Interventions

TypeNameDescription
OTHERAncillary-CorrelativeBlood samples are analyzed for activation status of B lymphocytes, T lymphocytes, and NK lymphocytes via flow cytometry, ELISA, ELISPOT, immunoblot, and microarray assays.

Timeline

Start date
2015-02-01
Primary completion
2016-12-01
First posted
2013-11-20
Last updated
2015-03-02

Source: ClinicalTrials.gov record NCT01988701. Inclusion in this directory is not an endorsement.